GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NKGen Biotech Inc (NAS:NKGN) » Definitions » Short-Term Capital Lease Obligation

NKGen Biotech (NKGen Biotech) Short-Term Capital Lease Obligation : $0.15 Mil (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is NKGen Biotech Short-Term Capital Lease Obligation?

NKGen Biotech's Short-Term Capital Lease Obligation for the quarter that ended in Mar. 2024 was $0.15 Mil.

NKGen Biotech's quarterly Short-Term Capital Lease Obligation declined from Sep. 2023 ($0.10 Mil) to Dec. 2023 ($0.00 Mil) but then increased from Dec. 2023 ($0.00 Mil) to Mar. 2024 ($0.15 Mil).

NKGen Biotech's annual Short-Term Capital Lease Obligation declined from Dec. 2021 ($0.46 Mil) to Dec. 2022 ($0.38 Mil) and declined from Dec. 2022 ($0.38 Mil) to Dec. 2023 ($0.00 Mil).

NKGen Biotech Short-Term Capital Lease Obligation Historical Data

The historical data trend for NKGen Biotech's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NKGen Biotech Short-Term Capital Lease Obligation Chart

NKGen Biotech Annual Data
Trend Dec21 Dec22 Dec23
Short-Term Capital Lease Obligation
0.46 0.38 -

NKGen Biotech Quarterly Data
Dec21 Sep22 Dec22 Mar23 Sep23 Dec23 Mar24
Short-Term Capital Lease Obligation Get a 7-Day Free Trial 0.38 - 0.10 - 0.15

NKGen Biotech Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

NKGen Biotech Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of NKGen Biotech's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

NKGen Biotech (NKGen Biotech) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NKGen Biotech Inc (NAS:NKGN) » Definitions » Short-Term Capital Lease Obligation
Comparable Companies
OCUP CASI SPRO XLO NGM GBIO ASMB CCCC OCEA FIXX OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
N/A
Address
19700 Fairchild Road, Suite No. 300, Irvine, CA, USA, 92612
Website
https://www.nkgenbiotech.com
NKGen Biotech Inc is a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous, allogeneic and CAR-NK natural killer cell therapies utilizing our proprietary SNK (super-activated) platform.